Eric Foster

Eric Foster currently serves as the Chief Commercial Officer at Ardelyx, Inc. since August 2024, bringing extensive experience in the pharmaceutical industry. Previously, Eric held senior leadership roles at Amgen and Horizon Therapeutics, overseeing the Rare Disease Business Unit and Gout & Ophthalmology Business Units, respectively. With a solid track record in P&L management and specialty and rare disease expertise, Eric has also contributed significantly at GSK in various capacities, including Vice President of Marketing for Immunology. Earlier in the career at Johnson & Johnson, Eric achieved notable recognition, including multiple Presidents Club awards. Eric holds an MBA with a Healthcare Concentration from Auburn University and a BA in Economics from the University of Georgia.